Surveillance of severe influenza-associated encephalopathy and related complications in US children
- Country
- United States
- Published
- January 16, 2026
- Deadline
- February 15, 2026
Description
{"description":" The specific goals of this project are to: \n\n \n\t Perform surveillance for severe IAE in hospitalized children with laboratory-confirmed influenza (age ≤18 years) using standardized case definitions. \n\t Collect detailed clinical information on identified IAE cases to assess risk factors for severe disease, describe the disease course and spectrum of disease, and assess the impact of different clinical interventions including influenza vaccination and antiviral medications. \n\t Assess influenza vaccination status of patients and other information about the hospital course by conducting medical record reviews and statewide vaccine registry reviews. \n \n\n SEE THE DRAFT PERFORMANCE WORK STATEMENT \n"} Solicitation Number: SS-75D301-2026 Type: Sources Sought Base Type: Sources Sought NAICS: 541380 Response Deadline: 2026-02-15T14:00:00-05:00 Office Address: ATLANTA, GA Place of Performance: Atlanta, Georgia, 30329 POC: ADA TORRES VEGA, cbp0@cdc.gov POC: Debra Baker, xvv9@cdc.gov {"description":" The specific goals of this project are to: \n\n \n\t Perform surveillance for severe IAE in hospitalized children with laboratory-confirmed influenza (age ≤18 years) using standardized case definitions. \n\t Collect detailed clinical information on identified IAE cases to assess risk factors for severe disease, describe the disease course and spectrum of disease, and assess the impact of different clinical interventions including influenza vaccination and antiviral medications. \n\t Assess influenza vaccination status of patients and other information about the hospital course by conducting medical record reviews and statewide vaccine registry reviews. \n \n\n SEE THE DRAFT PERFORMANCE WORK STATEMENT \n"}
Get tenders like this in one daily alert
Use this notice as context when Tenqual drafts your search scope and fit criteria.